Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection

被引:32
|
作者
Postigo, Antonio [1 ]
Martin, Morag C. [1 ]
Dodding, Mark P. [1 ]
Way, Michael [1 ]
机构
[1] Canc Res UK London Res Inst, London WC2A 3PX, England
关键词
PROSURVIVAL BCL-2; PIVOTAL ROLE; VIRUS; ACTIVATION; SURVIVAL; INTERACTS; 3-KINASE; LIGANDS; REVEAL; DOMAIN;
D O I
10.1111/j.1462-5822.2009.01327.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P>F1L is a functional Bcl-2 homologue that inhibits apoptosis at the mitochondria during vaccinia infection. However, the extent and timing of cell death during Delta F1L virus infection suggest that additional viral effectors cooperate with F1L to limit apoptosis. Here we report that vaccinia growth factor (VGF), a secreted virulence factor, promotes cell survival independently of its role in virus multiplication. Analysis of single and double knockout viruses reveals that VGF acts synergistically with F1L to protect against cell death during infection. Cell survival in the absence of F1L is dependent on VGF activation of the epidermal growth factor receptor. Furthermore, signalling through MEK kinases is necessary and sufficient for VGF-dependent survival. We conclude that VGF stimulates an epidermal growth factor receptor-MEK-dependent pro-survival pathway that synergizes with F1L to counteract an infection-induced apoptotic pathway that predominantly involves the BH3-only protein Bad.
引用
收藏
页码:1208 / 1218
页数:11
相关论文
共 12 条
  • [1] Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands
    M Kvansakul
    H Yang
    W D Fairlie
    P E Czabotar
    S F Fischer
    M A Perugini
    D C S Huang
    P M Colman
    Cell Death & Differentiation, 2008, 15 : 1564 - 1571
  • [2] Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands
    Kvansakul, M.
    Yang, H.
    Fairlie, W. D.
    Czabotar, P. E.
    Fischer, S. F.
    Perugini, M. A.
    Huang, D. C. S.
    Colman, P. M.
    CELL DEATH AND DIFFERENTIATION, 2008, 15 (10): : 1564 - 1571
  • [3] THE CHEMOKINE FRACTALKINE (CX3CL1) HAS ANTI-APOPTOTIC AND PROLIFERATIVE EFFECTS ON PRIMARY HUMAN SMOOTH MUSCLE CELLS VIA EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALLING
    White, G. E.
    Greaves, D. R.
    HEART, 2009, 95 (22)
  • [4] Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor
    Kawabata, Takumi
    Tanimura, Susumu
    Asai, Kohei
    Kawasaki, Ryohei
    Matsumaru, Yumi
    Kohno, Michiaki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (13) : 10289 - 10300
  • [5] Vascular endothelial growth factor receptor ligation differentially regulates primary human alveolar type II cell repair responses and is anti-apoptotic for sFasL but not 0.03% H2O2 induced cell death
    Pettigrew, K.
    Rathinam, Sri.
    Rajesh, P.
    Gao, F.
    Tetley, T.
    Thickett, D. R.
    THORAX, 2007, 62 : A2 - A2
  • [6] Transforming growth factor-β induced cell death in the developing chick retina is mediated via activation of c-jun N-terminal kinase and downregulation of the anti-apoptotic protein Bcl-XL
    Schuster, N
    Dünker, N
    Krieglstein, K
    NEUROSCIENCE LETTERS, 2002, 330 (03) : 239 - 242
  • [7] The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma
    Sasabe, Eri
    Tomomura, Ayumi
    Yamamoto, Tetsuya
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (05) : 310 - 320
  • [8] AMP-activated protein kinase protects against anti-epidermal growth factor receptor-Pseudomonas exotoxin A immunotoxin-induced MA11 breast cancer cell death
    Andersson, Y
    Le, H
    Juell, S
    Fodstad, O
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) : 1050 - 1059
  • [9] Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Hsu, Ping-Chih
    Jablons, David M.
    Yang, Cheng-Ta
    You, Liang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (15)
  • [10] Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study
    Wan, Chang
    Zhang, Yiruo
    Liu, Pingping
    Mei, Xinkuan
    Cheng, Gang
    Pang, Jingdan
    Chen, Sheng
    Xu, Jianping
    Malhotra, Jyoti
    Qian, Hesheng
    Du, Yingying
    JOURNAL OF THORACIC DISEASE, 2023, 15 (10) : 5648 - 5657